Results 101 to 110 of about 19,753 (208)

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial [PDF]

, 2010
Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, Kim Cocks, Sue Bell, Alex J. Szubert, Nuria Navarro-Coy, Mark T. Drayson, Roger G. Owen, Sylvia Feyler, A. John Ashcroft, Fiona Ross, Jenny Byrne, Huw Roddie, Claudius Rudin, Gordon Cook, Graham Jackson, J. Anthony Child   +17 more
openalex   +1 more source

Synergistic effect of graphene oxide and zoledronic acid for osteoporosis and cancer treatment [PDF]

, 2020
Gökçen Boran, Sepideh Tavakoli, Ingo Dierking, Ali Reza Kamali, Duygu Ege   +4 more
openalex   +1 more source

Delayed Inflammatory Reaction to Hyaluronic Acid Dermal Filler Following Zoledronic Acid Administration: A Case Report

Clinical, Cosmetic and Investigational Dermatology
Nada J Alghamdi,1,* Serene R Almuhaidib,2,* Abdulmajeed S Alharbi,2,* Abdullah Ali N Aljalfan,1,* Khalid M Al-Husain1 1Department of Dermatology, King Fahd University Hospital, Al Khobar, Saudi Arabia; 2College of Medicine, Imam ...
Alghamdi NJ, Almuhaidib SR, Alharbi AS, Aljalfan AAN, Al-Husain KM   +4 more
doaj  

Effectiveness of Sequential Treatment with Zoledronic Acid Following Discontinuation of Denosumab in Osteoporosis: A Narrative Review. [PDF]

Drug Des Devel Ther
Ouyang H, Yang F, Wei W, Wang W.
europepmc   +1 more source

Evaluate the renal system damage caused by zoledronic acid: A comprehensive analysis of adverse events from FAERS [PDF]

Zhaojun Wang, Xin Su, Donglei Shi, Wěi Li   +3 more
openalex   +1 more source

Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis [PDF]

, 2012
Steven Boonen, Jean‐Yves Reginster, Jean‐Marc Kaufman, Kurt Lippuner, José Zanchetta, Bente Langdahl, René Rizzoli, Stanley Lipschitz, Hans Peter Dimai, Richard Witvrouw, Erik Fink Eriksen, Kim Brixen, Luis Augusto Tavares Russo, Frank Claessens, P. Papanastasiou, Oscar Antúnez, Guoqin Su, Christina Bucci‐Rechtweg, Josef Hruska, Elodie Incera, Dirk Vanderschueren, Eric Orwoll   +21 more
openalex   +1 more source

Spinal Cord Infarction Following Zoledronic Acid Administration in a Patient With Metastatic Prostate Cancer. [PDF]

Cureus
Reid BE, Perez M, Abd Elmageed Z, DiGiuseppe S, Balbuena K.   +4 more
europepmc   +1 more source

Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway

, 2009
Marta Coscia, Elena Quaglino, Manuela Iezzi, Claudia Curcio, Francesca Pantaleoni, Chiara Riganti, Ingunn Holen, Hannu Mönkkönen, Mario Boccadoro, Guido Forni, Piero Musiani, Amalia Bosìa, Federica Cavallo, Massimo Massaia   +13 more
openalex   +2 more sources

The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose. [PDF]

Osteoporos Int
Konstantelos N, Kim S, Cheung AM, Burden AM, Grootendorst P, Cadarette SM.   +5 more
europepmc   +1 more source

Retraction: Zoledronic acid generates a spatiotemporal effect to attenuate osteoarthritis by inhibiting potential Wnt5a-associated abnormal subchondral bone resorption. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source